Applied Materials (AMAT) Declines More Than Market: Some Information for Investors

Applied Materials fell 3.79% to $446.63 in the latest session, versus a 1.11% decline for the S&P 500, though shares are up 10.23% over the past month. Ahead of its November 12, 2026 earnings release, consensus forecasts call for quarterly EPS of $4.06, up 87.1% year over year, and revenue of $10.3 billion, up 51.4%; the monthly consensus EPS estimate rose 0.16%. AMAT has a Zacks Rank of #2 (Buy), while its forward P/E of 36.3 matches the industry average.

Analysis

The key signal is not the stock’s one-day move but the mismatch between exceptionally strong published growth forecasts and only a 0.16% upward EPS revision over the past month. That may mean expectations are already demanding more than the incremental estimate trend supports; the reported 36.3x forward multiple leaves limited room for execution merely in line with forecasts. The article’s price-comparison sentence is internally inconsistent with its figures, so do not infer AMAT-specific underperformance from it.

Near term, the November 12, 2026 earnings release is the catalyst: the market will care more about forward wafer-fab equipment demand, order/backlog conversion, and China-related exposure than the backward-looking growth rate. Verify the source and scope of the unusually large quarterly year-over-year forecast increase before treating it as a durable run-rate. If customer spending or shipments are timing-driven, growth could decelerate while the multiple remains elevated. A further tightening of export restrictions or weaker customer capex plans could also pressure estimates; conversely, broad-based upward estimate revisions and firm forward commentary would validate the premium.

Second order: weaker or deferred fab investment would affect peers such as Lam Research, KLA, and Tokyo Electron, while a shift in spending mix between leading-edge logic and memory can create divergent tool demand. The article provides no evidence to rank those exposures, so avoid a peer pair on this information alone. Contrarian view: the dip after recent relative strength may be routine risk reduction rather than company-specific deterioration, but the modest revision signal argues against buying the growth narrative without confirmation.

Key Decisions for Investors

• No immediate directional trade on this article alone. Avoid chasing AMAT ahead of earnings; the forecast growth is not matched by meaningful recent estimate upgrades, and the supplied price comparison is inconsistent.
• Use the November 12 earnings event as a trigger: consider initiating or adding to a long only if management supports durable demand with order/backlog conversion and constructive forward guidance, and analyst estimates begin moving up beyond the current marginal revision.
• Alert: verify the basis and business scope behind the cited quarterly revenue and EPS growth forecasts, plus current China exposure and customer capex commentary. Treat a material downward guidance or estimate revision as a thesis-falsification signal; broad upward revisions and resilient orders would invalidate the cautious stance.